SFDA Chief Executive Officer Launches the 2nd. Saudi Conference for Drug Registration and Legislations

<p class="ms-rteElement-P">Under the auspice of H.E. SFDA Chief Executive Officer, Dr. Mohammed bin Abdul Rahman Al Misha’l, the 2nd. Saudi Conference for Drug Registration and Legislations, in the presence of national and international speakers in the field of pharmaceutical products and drug safety.<br />The conference was opened by reciting from the Holy Qur’an, followed by a speech <div></div>
<p class="ms-rteElement-P">delivered by the General Manager of Al Misnid Pharmaceutical Consultation Office, Abdullah Al Misnid- pharmacist, then followed by a speech by the Head of The Medical Committee of Riyadh Chamber of Commerce, Dr. Sami Al Abdulkareem, followed by SFDA Vice President for Drug Sector, Dr, Saleh Bawazir who thanked the conference organizers and speakers and overviewed SFDA Control role in registration of pharmaceutical products.<br />This was followed by the speech of H.E. CEO of SFDA, the conference sponsor, wherein he highlighted the legislative structure of drug market in the Kingdom and the control role exercised by SFDA in registration, tracking and quality of pharmaceutical products.<br />After that H.E. CEO of SFDA inaugurated the exhibition associated to this conference, toured and overviewed the exhibition stands of the participating entities.</p></p>
<p> </p>